Differential blood cellular profile in patients with moderate‐to‐severe psoriasis treated with classical systemic therapies: a step forward in personalized medicine von Hernández‐Breijo, B., Jurado, T., Rodríguez‐Martín, E., Martínez‐Feito, A., Plasencia‐Rodríguez, C., Balsa, A., Alonso‐Pacheco, M.L., Villar, L.M., Herranz‐Pinto, P., Pascual‐Salcedo, D.

Volltext

SP0127 Basic Concepts: Analysis of Anti-Drug Antibodies and Serum Concentrations of Biologicals von Pascual-Salcedo, D.

Volltext

Epistatic interaction between FCRL3 and NFκB1 genes in Spanish patients with rheumatoid arthritis von Martínez, A, Sánchez, E, Valdivia, A, Orozco, G, López-Nevot, M A, Pascual-Salcedo, D, Balsa, A, Fernández-Gutiérrez, B, de la Concha, E G, García-Sánchez, A, Koeleman, B P C, Urcelay, E, Martín, J

Volltext

IL-6 promoter polymorphisms in rheumatoid arthritis von Pascual, M, Nieto, A, Matarán, L, Balsa, A, Pascual-Salcedo, D, Martín, J

Volltext

OP0016 Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IGG1 Allotypes and Treated with Anti-TNF Antibodies von Lόpez-Rodríguez, R., Martínez, A., Plasencia, C., Jochems, A., Pascual-Salcedo, D., Balsa, A., Gonzalez, A.

Volltext

AB0656 Clinical Relevance of Measuring Free versus Total Anti-Infliximab Antibodies in Patients with Spondyloarthritis von Ruiz del Agua, A., Pascual, J., Torres, N., Pascual-Salcedo, D., Martínez, A., Jurado, T., Plasencia, C., Balsa, A., Ruiz-Argüello, B., Maguregui, A., Ametzazurra, A., Martínez, A., Nagore, D.

Volltext

AB0284 Influence of Smoking in the Characteristics of Rheumatic Arthritis of Recent Onset von Nuño, L., Franco, K., Peiteado, D., Villalba, A., Pascual-Salcedo, D., Martin Mola, E., Balsa, A.

Volltext

FRI0169 Influence of Body Mass Index (BMI) on Serum Levels of Infliximab in Patients with Rheumatoid Arthritis (RA) von Villalba Yllan, A., Navarro Compan, M.V., Plasencia Rodriguez, C., Peiteado Lopez, D., Bonilla Hernan, G., Nuño Nuño, L., Pascual-Salcedo, D., Olariaga, E., Balsa Criado, A., Martin Mola, E.

Volltext

OP0015 Antibodies To Infliximab in Remicade-Treated Rheumatic Patients Show Identical Reactivity towards Biosimilar CT-P13 von Ruiz-Argüello, B., Maguregui, A., Ruiz del Agua, A., Pascual-Salcedo, D., Martínez, A., Jurado, T., Plasencia, C., Balsa, A., Rosas, J., Llinares-Tello, F., Torres, N., Martínez, A., Nagore, D.

Volltext

AB0660 Predictors of Flare after Tapering Anti-TNF Therapy in Patients with Axial Spondyloarthritis von Monjo Henry, I., Plasencia, C., Navarro-Compán, V., Paredes, B., Bonilla, G., Nuño, L., Peiteado, D., Villalba, A., Pascual-Salcedo, D., Ramiro, S., de Miguel, E., Martín-Mola, E., Balsa, A.

Volltext

SAT0414 In Spondyloarthritis; Does Immunogenicity Influence on Drug Survival of anti-TNF? von García-Carazo, S., Plasencia, C., Pascual-Salcedo, D., Peiteado, D., Bonilla, G., Nuño, L., Villalba, A., Díaz, M., Arribas, F., Balsa, A.

Volltext

FRI0212 Comparison Study of Tests Available To Monitor Tocilizumab Therapy in Rheumatic Patients von Martín, S., Ruiz del Agua, A., Torres, N., Pascual-Salcedo, D., Plasencia, C., Jurado, T., Martínez, A., Balsa, A., Ruiz-Argüello, B., Martínez, A., Navarro, R., Nagore, D.

Volltext

Asporin repeat polymorphism in rheumatoid arthritis von Torres, B, Orozco, G, García-Lozano, J R, Oliver, J, Fernández, O, González-Gay, M A, Balsa, A, García, A, Pascual-Salcedo, D, López-Nevot, M A, Núñez-Roldán, A, Martín, J, González-Escribano, M F

Volltext

FRI0167 Low Levels of Infliximab at Early Stages Predict The Loss of Drug Levels and The Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis von Jurado, T., Plasencia, C., Martínez-Feito, A., Navarro-Compán, V., Olariaga, E., Diego, C., Martin-Mola, E., Balsa, A., Pascual-Salcedo, D.

Volltext

AB0657 Discontinuation of Anti-TNF Therapy in Patients with Axial Spondyloarthritis in Clinical Practice: Prevalence and Causes von Moral, E., Plasencia, C., Navarro-Compán, V., Pascual Salcedo, D., Jurado, T., Tornero, C., Pierens, A., Paredes, M.B., Bogas, P., Monjo, I., Martin Mola, E., Balsa, A.

Volltext

FRI0168 Effect of Methotrexate in The Presence of Drug and The Appearance of Antibodies against TNF Inhibitors in Patients with Rheumatoid Arthritis von Martínez-Feito, A., Plasencia, C., Villalba, A., Jurado, T., Mezcua, A., Martín-Mola, E., Bonilla, G., Balsa, A., Pascual-Salcedo, D.

Volltext

AB0302 Influence of Tapering Biological Therapies in Immunogenicity in A Cohort of Rheumatoid Arthritis with Low Disease Activity von Paredes, B., Plasencia, C., Balsa, A., Monjo, I., Pascual-Salcedo, D., Pieren, A., Moral, E., Tornero, C., Bogas, P., Bonilla, G., Nuño, L., Villalba, A., Peiteado, D., Ramiro, S., Jurado, T., Díez, J., Martin-Mola, E.

Volltext

SAT0157 Tocilizumab Serum Trough Levels Correlate with Clinical Activity in Rheumatoid Arthritis von Tornero Marín, C., Plasencia, C., Pascual Salcedo, D., Jurado, T., Paredes, M.B., Monjo, I., Moral, E., Pieren, A., Bonilla Hernán, G., Peiteado, D., Bogas, P., Nuño, L., Villalba Yllan, A., Martín Mola, E., Balsa Criado, A.

Volltext

SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis von Kneepkens, E.L., van den Oever, I.A., Plasencia, C.H., Pascual-Salcedo, D., van der Kleij, D., Hart, M., Nurmohamed, M.T., Balsa, A., Aarden, L., Rispens, T., Wolbink, G.J.

Volltext

The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis t... von Plasencia, Ch, Pascual-Salcedo, D, Alcocer, P, Bonilla, M G, Villalba, A, Peiteado, D, Arribas, F, Díez, J, Lopez-Casla, M T, Martín-Mola, E, Balsa, A

Volltext